BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the appointment of veteran public company operator John P. Gorst as Chief Executive Officer, effective immediately. The move comes as the company advances toward the anticipated closing of its previously announced acquisition of Ancient Extracts USA and broader platform expansion initiatives.
Jordan P. Balencic, who previously served as CEO, will remain Chairman and transition into the role of Chief Science Officer, focusing on strategic growth, acquisition strategy, product development, and long-term platform vision. The leadership change signals a strategic shift to bolster operational execution and corporate governance as BFCH scales its wellness platform.
Mr. Gorst brings more than 30 years of experience in public company leadership, consumer products, manufacturing, and capital markets. He has participated in raising over $100 million through equity financings, PIPE transactions, and debt offerings, and has been involved in two eight-figure business exits. Management expects Mr. Gorst to drive operational execution, acquisition integration, commercialization, strategic partnerships, and fundraising efforts.
The appointment comes as BFCH finalizes definitive agreements for the acquisition of Ancient Extracts USA, a post-revenue wellness platform with a direct-to-consumer infrastructure, growing customer base, and active commercialization. Following the closing, the company expects to announce initial purchase orders and additional commercial developments as Ancient Extracts USA scales operations and pursues retail opportunities.
“What excites me most is how naturally all of this fits together,” said Dr. Balencic. “Ancient Extracts USA already has a commercial foundation in place, and Mr. Gorst brings decades of operational, manufacturing, consumer products, and capital markets experience. Our skill sets complement each other extremely well, and we are already identifying multiple opportunities to expand the platform, create strategic synergies, and accelerate growth.”
Dr. Balencic emphasized that the company is not focused on a single acquisition but is building a scalable operating platform for consumer wellness and commercialization. Mr. Gorst echoed this sentiment, stating, “What attracted me to BFCH is that this is more than a turnaround story. Ancient Extracts USA already has products, customers, revenue, infrastructure, and momentum in place. I believe there is a significant opportunity to scale the platform through disciplined execution, expanded distribution, strategic partnerships, and additional operating assets.”
In addition to his CEO role, Mr. Gorst is expected to join the Board of Directors and will immediately initiate the formation of audit and compensation committees to enhance corporate governance, support future audits, and expand the board. The company also plans to align executive compensation with long-term operational execution and shareholder value creation.
BFCH continues to evaluate additional acquisition opportunities, strategic partnerships, and operating assets aligned with its focus on consumer wellness, functional products, and human optimization. The company’s platform includes internally developed and acquired brands, such as EVERMIND™, a cognitive health beverage platform in development.
For corporate information, visit UNLOCKDinc.com. View current filings on OTC Markets.
